MTOR and head and neck squamous cell carcinoma: We also examined the mTOR pathway, which is downstream of PI3K, not only because it is dysregulated in HPV+ HNSCC but also because mTOR inhibitors show promising anticancer effects in HPV+ HNSCC mouse models (75).